#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS

Insulin pump therapy and hypoglycemia

Czech version

Authors: Dana Prídavková;  Udovít Šutarík;  Peter Galajda;  Marián Mokáň
Authors‘ workplace: I. Interná klinika JLF UK a UN Martin
Published in: Forum Diab 2020; 9(1): 43-48
Category:

Overview

Treatment with continuous subcutaneous insulin infusion (CSII) or insulin pump (IP) with rapid-acting insulin analogues allows a more physiologic insulin replacement and may thus contribute to improved glycemic – metabolic control not only in patients with diabetes mellitus type 1 (DM1T), but also in suitable patients with diabetes mellitus typ 2 (DM2T). Reduced risk of severe hypoglycemia during treatment of CSII is associated with lower total daily insulin dose and a higher proportion of bolus insulin. CSII allowss a flexible therapy with lower glycemic variability, leading to reduced risk of acute and long-term diabetes complications.

Keywords:

diabetes mellitus – continuous subcutaneous insulin infusion – hypoglycemia – hypoglycemia unawareness

Sources
  1. Bally L, Thabit H, Hovorka R. Finding the right route for insulin delivery – an overview of implantable pump therapy. Expert Opin Drug Deliv 2017; 14(9): 1103–1111. Dostupné z DOI: <http://dx.doi.org/10.1080/17425247.2017.1267138>.
  2. Thabit H, Hovorka R. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons. Expert Opin Drug Deliv 2016; 13(3): 389–400. Dostupné z DOI: <http://dx.doi.org/10.1517/17425247.2016.1115013>.
  3. [American Diabetes Association]. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43(Suppl 1): S66-S76. Dostupné z DOI: <http://dx.doi.org/10.2337/dc20-S006>.
  4. Gerstein HC, Miller ME, Byington RP et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358(24): 2545–2559. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa0802743>.
  5. Zoungas S, Patel A, Chalmers J et al. [ADVANCE Collaborative Group] . Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010; 363(15): 1410–1418. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1003795>.
  6. Jacobson AM, Musen G, Ryan CM et al. [Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group]. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007; 356(18): 1842–1852. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa066397>. Erratum in N Engl J Med 2009; 361(19): 1914.
  7. Shalimova A, Graff B, Gasecki D et al. Cognitive Dysfunction in Type 1 Diabetes MellitusJ Clin Endocrinol Metab 2019; 104(6): 2239–2249. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2018–01315>.
  8. Allen NA, Litchman ML, May AL et el. Using advanced diabetes technologies in patients with dementia in assisted living facilities: Case studies. Cogent Medicine 2017; 4(1): 1411632. Dostupné z DOI: https://doi.org/10.1080/2331205X.2017.1411632> .
  9. American Diabetes Association. 6. Glycemic Targets. Diabetes Care 2015; 38(Suppl 1): S33–S40. Dostupné z DOI: <http://dx.doi.org/10.2337/dc15-S009>.
  10. Seaquist ER, Anderson J, Childs B et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013; 36(5): 1384–1395. Dostupné z DOI: <http://doi: 10.2337/dc12–2480>.
  11. Davis RE, Morrissey M, Peters JR et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005;21(9): 1477–1483. Dostupné z DOI: <http://dx.doi.org/10.1185/030079905X61929>.
  12. Gonder-Frederick LA, Vajda KA, Schmidt KM et al. Examining the Behaviour subscale of the Hypoglycaemia Fear Survey: an international study. Diabet Med 2013; 30(5): 603–609. Dostupné z DOI: <http://dx.doi.org/10.1111/dme.12129>.
  13. Speight J, Barendse SM, Singh H et al. Cognitive, behavioural and psychological barriers to the prevention of severe hypoglycaemia: A qualitative study of adults with type 1 diabetes. SAGE Open Med 2014; 2: 2050312114527443. Dostupné z DOI: <http://10.1177/2050312114527443>.
  14. Shaban C, Knott J, Jenkins E et al. Diabetes distress and fear of hypoglycaemia: what are the psychological benefits of insulin pump therapy? Pract Diab 2017: 34(8): 273–276.
  15. Pedersen-Bjergaard U, Pramming S, Heller SR et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004; 20(6): 479–486. Dostupné z DOI: <http://dx.doi.org/10.1002/dmrr.482>.
  16. Buckingham B, Chase P, Dassau E et al. Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension. Diabetes Care 2010; 33(5): 1013–1017. Dostupné z DOI: <http://dx.doi.org/10.2337/dc09–2303>.
  17. Cryer PE. Hypoglycemia in Diabetes. Pathophysiology, Prevalence, and Prevention. 3rd ed. Amer Diabetes Ass 2016. ISBN 978–1580406499
  18. Khunti K, Alsifri S, Aronson R et al. Rates and predictors of hypoglycaemia in 27585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab 2016; 18(9): 907–915. Dostupné z DOI: <http://dx.doi.org/10.1111/dom.12689>.
  19. Weinstock RS, Xing D, Maahs DM et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D exchange clinic registry. J Clin Endocrinol Metab 2013; 98(3): 3411–3419. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2013–1589>.
  20. [International Hypoglycaemia Study Group]. Minimizing Hypoglycemia in Diabetes. Diabetes Care 2015; 38(8): 1583–1591. Dostupné z DOI: <http://dx.doi.org/10.2337/dc15–0279>.
  21. Didangelos F, Iliadis F. Insulin pump therapy in adults. Diab Res Clin Pract 2011; 93(Suppl 1): S109-S113. Dostupné z DOI: <http://dx.doi.org/10.1016/S0168–8227(11)70025–0>.
  22. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008; 25(7): 765–774. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1464–5491.2008.02486.x>.
  23. Karges B, Schwandt A, Heidtmann B et al. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. JAMA 2017; 318(14): 1358–1366. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2017.13994>.
  24. [Joint British Diabetes Societies (JBDS) Inpatient Care Working Group members].The Hospital Management of Hypoglycaemia in Adults with Diabetes Mellitus. 3rd ed. Revised Febr 2018. Dostupné z WWW: <http://www.diabetes.org.uk/joint-british-diabetes-society>.
  25. Reznik Y, Cohen O, Aronson R et al. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet 2014; 384(9950): 1265–1272. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(14)61037–0>.
  26. Šoupal J, Petruželková L, Grunberge G et al. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR study. Diabetes Care 2020; 43(1): 37–43. Dostupné z DOI: <http://dx.doi.org/10.2337/dc19–0888>.
  27. Thomakos P, Vazeou A, Sakkas D et al. Avoiding hypoglycemia: the use of insulin pump combined with continuous glucose monitor in type 1 diabetes crossing a Rocky Gorge. QJM 2018; 111(9): 629–633. Dostupné z DOI: <http://dx.doi.org/10.1093/qjmed/hcy136>.
  28. Medtronic data on file: SmartGuard real life data. Medtronic MiniMed evaluated using the voluntary MiniMed 640G uploads to CareLink Personal from Jan. 13th 2015 to Jan. 14th 2016. Dostupné z WWW: <https://hcp.medtronic-diabetes.co.uk/files/2016/09/minimed-640g-insights-hcp-mmol-brochure.pdf>.
  29. Forlenza GP, Li Z, Buckingham BA et al. Predictive low glucose suspend reduces hypoglycaemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study. Results of the PROLOG trial. Diabetes Care 2018; 41(10): 2155–2161. Dostupné z DOI: <http://dx.doi.org/10.2337/dc18–0771>.
  30. Chen E, King F, Kohn MA et al. A Review of Predictive Low Glucose Suspend and Its Effectiveness in Preventing Nocturnal Hypoglycemia. Diabetes Technol Ther 2019; 21(10): 602–609. Dostupné z DOI: <http://dx.doi.org/10.1089/dia.2019.0119>.
  31. Ly TT, Nicholas JA, Retterath A et al. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013; 310(12): 1240–1247. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2013.277818>.
  32. Bergenstal RM, Klonoff DC, Garg SK et al.Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013; 369(3): 224–232. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1303576>.
  33. Bode B, Beck RW, Xing D et al. [Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group]. Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care 2009; 32(11): 2047–2049. Dostupné z DOI: <http://dx.doi.org/10.2337/dc09–0846>.
  34. Rickels MR, Peleckis AJ, Dalton-Bakes C et al. Continuous Glucose Monitoring for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes. J Clin Endocrinol Metab 2018; 103(1): 105–114. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2017–01516>.
  35. Ly TT, Gallego PH, Davis EA et al. Impaired awareness of hypoglycaemia in a population-based sample of children and adolescents with Type 1 diabetes. Diabetes Care 2009; 32(10): 1802–1806. Dostupné z DOI: <http://dx.doi.org/10.2337/dc09–0541>.
  36. Zalzali M, Houdelet-Guerinot V, Socquard E et al. Continuous glucose monitoring and hypoglycemia unawareness in type 1 diabetes: a pilot study. Minerva Endocrinol 2017; 42(3): 195–202. Dostupné z DOI: <http://dx.doi.org/10.23736/S0391–1977.16.02326–9>.
  37. Cappon G, Vettoretti M, Sparacino G et al. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications. Diabetes Metab J 2019; 43(4): 383–397. Dostupné z DOI: <http://dx.doi.org/10.4093/dmj.2019.0121>.
  38. Spanakis EK, Cryer PE, Davis SN. Hypoglycemia During Therapy of Diabetes. [Updated 2018 Jun 18]. In: Feingold KR, Anawalt B, Boyce A, et al (eds). Endotext [Internet]. South Dartmouth(MA): MDText.com, Inc.; 2000. Dostupné z WWW: <https://www.ncbi.nlm.nih.gov/books/NBK279100/>.
  39. Ziegler R, Freckmann G, Heinemann L. Boluses in Insulin Therapy: A Commentary. J Diabetes Sci Technol 2017; 11(1): 165–171. Dostupné z DOI: <http://dx.doi.org/10.1177/1932296816653142>.
  40. Štechová K. Léčba inzulinovou pumpou. Interní Med 2013; 15(2): 64–68. Dostupné z WWW: <https://www.internimedicina.cz/pdfs/int/2013/02/05.pdf>.
  41. Ziegler R, Kiess W. Hypoglykämien bei Kindern und Jugendlichen mit Typ-1-Diabetes. Diabetologie 2013; 9(2): 111–116. Dostupné z WWW: <https://link.springer.com/article/10.1007%2Fs11428–012–0976–0>.
Labels
Diabetology Endocrinology Internal medicine
Hypoglykémia ako limitujúci faktor liečby diabetes mellitus
Risk of hypoglycemia in patients with diabetes mellitus and comorbidities
Clinical characteristics of patients with type 2 diabetes mellitus based on hypoglycemia frequency
Glucose metabolism after kidney transplantation
Hypoglycemia and sport
Hypoglycemia and acute coronary syndrome
Hypoglycemia in prisoners
Education of patients with hypoglycemia
Plant-based diet according to the NFI protocol in patients with type 2 diabetes mellitus: pilot study
The BRIGHT study (a “head-to-head” comparison of insulin Glargine 300 U/ml and insulin Degludek 100 U/ml): The comments on the more recent analyses of results
Ako využívame prínosy SGLT2-inhibítorov v klinickej praxi na Slovensku
Elderly patient, fragility, and cardiovascular disease
Autodidaktický test hodnotený kreditmi ARS CME
Z odbornej literatúry
Article was published in

Forum Diabetologicum

Issue 1
2020 Issue 1
Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#